Spirepoint Private Client’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$465K Buy
2,488
+368
+17% +$67.7K 0.04% 216
2026
Q1
$400K Buy
2,120
+580
+38% +$122K 0.04% 211
2025
Q4
$306K Buy
+1,540
New +$311K 0.03% 238

Other funds holding THC

Spirepoint Private Client's THC Position: Q2 2026 in Review

Spirepoint Private Client increased its Tenet Healthcare (THC) stake by 17% in Q2 2026, buying an estimated $67.7K and bringing the position to 2,488 shares worth $465K. The position accounts for 0.04% of the portfolio, ranked #216.

Spirepoint Private Client first reported a position in THC in Q4 2025 and has held it in 3 quarters since. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Spirepoint Private Client held 2,488 shares of Tenet Healthcare worth $465K as of Q2 2026.
  • Spirepoint Private Client bought 368 Tenet Healthcare shares in Q2 2026, an estimated $67.7K.
  • Tenet Healthcare made up 0.04% of Spirepoint Private Client's portfolio in Q2 2026, its #216 holding.
  • Spirepoint Private Client first reported a position in Tenet Healthcare in Q4 2025 and has held it in 3 quarters since.
  • 679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Spirepoint Private Client's 13F filing for Q2 2026, filed 5 Aug 2026.